NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
May 28, 2024
Dan joins NodThera with over 30 years of pharmaceutical industry leadership experience, including as President and COO of Jazz Pharmaceuticals and CEO of Sunesis Pharmaceuticals